Literature DB >> 24266346

Regulation of antiviral CD8 T-cell responses.

Joseph M Kulinski1, Vera L Tarakanova, James Verbsky.   

Abstract

A balanced immune response to a viral pathogen leads to clearance of the virus while limiting immune mediated pathology. Control of this process occurs at all stages of the immune response, including during the induction of an antiviral response, clearance of virally infected cells, and the resolution of this response. Regulation of antiviral immune response is further modified when the immune system fails to clear the pathogen and by the nature of chronic infection itself. A number of processes have been implicated in the regulation of antiviral immune responses, such as the limitation of viral antigen load by interferons, apoptosis through cytokine withdrawal or Fas-mediated killing, and control of these responses by regulatory T cells. This review addresses several of these mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24266346      PMCID: PMC4729194          DOI: 10.1615/critrevimmunol.2013007909

Source DB:  PubMed          Journal:  Crit Rev Immunol        ISSN: 1040-8401            Impact factor:   2.214


  111 in total

Review 1.  Molecular mechanisms of caspase regulation during apoptosis.

Authors:  Stefan J Riedl; Yigong Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

2.  T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

Authors:  Tobias Boettler; Hans Christian Spangenberg; Christoph Neumann-Haefelin; Elisabeth Panther; Simonetta Urbani; Carlo Ferrari; Hubert E Blum; Fritz von Weizsäcker; Robert Thimme
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

Review 3.  Induction and function of IFNβ during viral and bacterial infection.

Authors:  Uma Nagarajan
Journal:  Crit Rev Immunol       Date:  2011       Impact factor: 2.214

4.  Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase.

Authors:  Andrew L Mellor; Phillip Chandler; Babak Baban; Anna M Hansen; Brendan Marshall; Jeanene Pihkala; Herman Waldmann; Stephen Cobbold; Elizabeth Adams; David H Munn
Journal:  Int Immunol       Date:  2004-09-06       Impact factor: 4.823

5.  Immune responses in interleukin-2-deficient mice.

Authors:  T M Kündig; H Schorle; M F Bachmann; H Hengartner; R M Zinkernagel; I Horak
Journal:  Science       Date:  1993-11-12       Impact factor: 47.728

6.  Antigen-driven effector CD8 T cell function regulated by T-bet.

Authors:  Brandon M Sullivan; Amy Juedes; Susanne J Szabo; Matthias von Herrath; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

Review 7.  Cell-death signaling and human disease.

Authors:  Frédéric Rieux-Laucat; Alain Fischer; Françoise Le Deist
Journal:  Curr Opin Immunol       Date:  2003-06       Impact factor: 7.486

8.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells.

Authors:  Matthew A Williams; Aaron J Tyznik; Michael J Bevan
Journal:  Nature       Date:  2006-06-15       Impact factor: 49.962

9.  Defective IL-10 signaling in hyper-IgE syndrome results in impaired generation of tolerogenic dendritic cells and induced regulatory T cells.

Authors:  Masako Saito; Masayuki Nagasawa; Hidetoshi Takada; Toshiro Hara; Shigeru Tsuchiya; Kazunaga Agematsu; Masafumi Yamada; Nobuaki Kawamura; Tadashi Ariga; Ikuya Tsuge; Shigeaki Nonoyama; Hajime Karasuyama; Yoshiyuki Minegishi
Journal:  J Exp Med       Date:  2011-02-07       Impact factor: 14.307

Review 10.  CD8(+) T cells: foot soldiers of the immune system.

Authors:  Nu Zhang; Michael J Bevan
Journal:  Immunity       Date:  2011-08-26       Impact factor: 31.745

View more
  11 in total

1.  STIM1 controls T cell-mediated immune regulation and inflammation in chronic infection.

Authors:  Ludovic Desvignes; Carl Weidinger; Patrick Shaw; Martin Vaeth; Theo Ribierre; Menghan Liu; Tawania Fergus; Lina Kozhaya; Lauren McVoy; Derya Unutmaz; Joel D Ernst; Stefan Feske
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

2.  Correlation of the Imbalance in the Circulating Lymphocyte Subsets With C-Reactive Protein and Cardio-Metabolic Conditions in Patients With COVID-19.

Authors:  Anton V Tyurin; Milyausha K Salimgareeva; Ildar R Miniakhmetov; Rita I Khusainova; Alexandr Samorodov; Valentin N Pavlov; Julia Kzhyshkowska
Journal:  Front Immunol       Date:  2022-05-06       Impact factor: 8.786

3.  Landscape and Selection of Vaccine Epitopes in SARS-CoV-2.

Authors:  Christof C Smith; Sarah Entwistle; Caryn Willis; Steven Vensko; Wolfgang Beck; Jason Garness; Maria Sambade; Eric Routh; Kelly Olsen; Julia Kodysh; Timothy O'Donnell; Carsten Haber; Kirsten Heiss; Volker Stadler; Erik Garrison; Oliver C Grant; Robert J Woods; Mark Heise; Benjamin G Vincent; Alex Rubinsteyn
Journal:  bioRxiv       Date:  2020-06-04

Review 4.  Peptides to combat viral infectious diseases.

Authors:  Shams Al-Azzam; Yun Ding; Jinsha Liu; Priyanka Pandya; Joey Paolo Ting; Sepideh Afshar
Journal:  Peptides       Date:  2020-09-01       Impact factor: 3.750

Review 5.  Acute SARS-CoV-2 pneumonitis with cytotoxic CD8 positive T-lymphocytes: Case report and review of the literature.

Authors:  Andrii Puzyrenko; Juan C Felix; Yunguang Sun; Hallgeir Rui; Yuri Sheinin
Journal:  Pathol Res Pract       Date:  2021-02-15       Impact factor: 3.309

Review 6.  Host-virus interaction and viral evasion.

Authors:  Scheilla T Strumillo; Denis Kartavykh; Fábio F de Carvalho; Nicolly C Cruz; Ana C de Souza Teodoro; Ricardo Sobhie Diaz; Marli F Curcio
Journal:  Cell Biol Int       Date:  2021-02-19       Impact factor: 4.473

7.  Pathological and immunological characterization of bluetongue virus serotype 1 infection in type I interferons blocked immunocompetent adult mice.

Authors:  Mani Saminathan; Karam Pal Singh; Madhulina Maity; Sobharani Vineetha; Gundallhalli Bayyappa Manjunathareddy; Kuldeep Dhama; Yashpal Singh Malik; Muthannan Andavar Ramakrishnan; Jyoti Misri; Vivek Kumar Gupta
Journal:  J Adv Res       Date:  2021-01-20       Impact factor: 10.479

8.  Landscape and selection of vaccine epitopes in SARS-CoV-2.

Authors:  Christof C Smith; Kelly S Olsen; Benjamin G Vincent; Alex Rubinsteyn; Kaylee M Gentry; Maria Sambade; Wolfgang Beck; Jason Garness; Sarah Entwistle; Caryn Willis; Steven Vensko; Allison Woods; Misha Fini; Brandon Carpenter; Eric Routh; Julia Kodysh; Timothy O'Donnell; Carsten Haber; Kirsten Heiss; Volker Stadler; Erik Garrison; Adam M Sandor; Jenny P Y Ting; Jared Weiss; Krzysztof Krajewski; Oliver C Grant; Robert J Woods; Mark Heise
Journal:  Genome Med       Date:  2021-06-14       Impact factor: 15.266

9.  mRNA-encoded, constitutively active STINGV155M is a potent genetic adjuvant of antigen-specific CD8+ T cell response.

Authors:  Sze-Wah Tse; Kristine McKinney; William Walker; Mychael Nguyen; Jared Iacovelli; Clayton Small; Kristen Hopson; Tal Zaks; Eric Huang
Journal:  Mol Ther       Date:  2021-03-05       Impact factor: 12.910

10.  Modulation of Tregs and iNKT by Fingolimod in Multiple Sclerosis Patients.

Authors:  Diana Ferraro; Sara De Biasi; Anna Maria Simone; Riccardo Orlandi; Milena Nasi; Francesca Vitetta; Marcello Pinti; Marco Fogliani; Stefano Meletti; Andrea Cossarizza; Patrizia Sola
Journal:  Cells       Date:  2021-11-26       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.